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Abstract
Background: Few studies have explored the association between a previous caesarean section (CS) and adverse
perinatal outcomes in a subsequent pregnancy, especially in women who underwent a non-indicated CS in their
first delivery. We designed this study to compare the perinatal outcomes of a subsequent pregnancy in women
who underwent spontaneous vaginal delivery (SVD) or CS in their first delivery.
Methods: This retrospective cohort study included women who underwent singleton deliveries at the International
Peace Maternity and Child Health Hospital from January 2013 to December 2016. Data on the perinatal outcomes
of all the women were extracted from the medical records. Multivariate logistic regression was conducted to
assessed the association between CS in the first delivery and adverse perinatal outcomes in the subsequent
pregnancy.
Results: CS delivery in the subsequent pregnancy was more likely for women who underwent CS in their first birth
than for women with previous SVD (97.3% versus 13.2%). CS in the first birth was also associated with a significantly
increased risk of adverse outcomes in the subsequent pregnancy, especially in women who underwent a non-
indicated CS. Adverse perinatal outcomes included pregnancy-induced hypertension [adjusted odds ratio (OR), 95%
confidence interval (CI): 2.20, 1.59–3.05], gestational diabetes mellitus (1.82, 1.57–2.11), gestational anaemia (1.27, 1.
05–1.55), placenta previa (3.18, 2.15–4.71), placenta accreta (2.75, 1.75–4.31), and polyhydramnios (2.60, 1.57–4.31) in
the mother and preterm delivery (1.37, 1.06–1.78), low birth weight (3.78, 2.07–6.90), macrosomia (5.04, 3.95–6.44),
and neonatal jaundice (1.72, 1.39–2.14) in the baby.
Conclusions: CS in the first delivery markedly increases the risk of repeated CS and maternal-fetal complications in
the subsequent pregnancy, especially in women with a non-indicated CS.
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Background
The high prevalence of caesarean section (CS) is a
global public health issue. According to a WHO
statement in 1985, regional CS rates should not ex-
ceed 10–15% [1, 2]. However, the rate of CS has
markedly increased from approximately 6 to 40% in
low, medium and high income countries in the past
three decades [3–6]. China has a high rate of CS as
well as CS without medical indication [4, 6]. Between
1988 and 2010, caesarean rates in all of China rose
from 3.4 to 52.5%, while urban rates increased from
10 to 57% [7, 8]. Maternal request and previous CS
are the most common indications for CS in mainland
China [9]. According to a large, cross-sectional study
of 496,054 caesarean deliveries, the prevalence of pri-
mary non-indicated CS increased from 0.6% in 1993–
1995 to 21.3% in 2006–2010 [10]. Other studies have
reported national rates of non-indicated CS ranging
from 28.43 to 38.1% in China [9, 11]. Prior CS is an
important factor in the determination of a subsequent
CS, which has led to overall high CS rates [6]. As im-
plementation of China’s ‘two-child policy’ has trig-
gered the next baby boom, many women with a
previous CS might require repeated CS in their subse-
quent deliveries [9, 12]. Thus, the adverse outcomes
in subsequent pregnancies for Chinese women with a
previous CS must be further surveyed.
Although CS is accepted as a fairly safe procedure,
and the overall rates of CS complications have de-
creased during the last decade [13], CS is still associ-
ated with an increased risk of maternal complications.
According to recent data up to 2015, the WHO an-
nounced that CS rates higher than 10% were not as-
sociated with reductions in maternal and newborn
mortality rates at the population level [2, 14, 15]. The
WHO global survey indicated that caesarean delivery
was positively associated with an increased risk of
postpartum antibiotic use, maternal morbidity and
mortality, and fetal and neonatal morbidity [3, 4].
Furthermore, prior CS was significantly associated
with a deficit in subsequent fertility [16–19] and an
increased risk of unexplained stillbirth in the subse-
quent pregnancy [20, 21]. Repeated CS was reported
to increase maternal morbidity, including placenta
accreta, reduced fetal growth, preterm delivery, pelvic
pain, and adverse reproductive effects [22, 23]. How-
ever, few studies [24–27] of the Chinese population
have explored the association between previous CS
and adverse perinatal outcomes in a subsequent preg-
nancy, especially in women with a first non-indicated
CS. Thus, we designed this study to compare the
perinatal outcomes of subsequent pregnancies in
women with a first spontaneous vaginal delivery to
those with a CS.
Methods
Data source
The data for this study were obtained from the databases
of the International Peace Maternity and Child Health
Hospital. The perinatal database contains pregnancy, de-
livery, and pregnancy outcome data for all births submit-
ted as paper copies of the delivery record or through an
electronic extract in this hospital. Validation was per-
formed on the data to check for errors and inconsisten-
cies in documentation and coding. This study was
performed in accordance with the declaration of
Helsinki. Complications related to pregnancy and deliv-
ery, as well as related co-morbidities, were coded using
criteria taken from the 9th and 10th revisions of the
International Classification of Diseases (ICD-9 and -10).
Study population
In this retrospective study, we included all parous
women who underwent a singleton delivery at the Inter-
national Peace Maternity and Child Health Hospital
from January 2013 to December 2016. Subjects with
missing information on the previous mode of delivery,
with multiple pregnancies in the first birth, or with par-
ity over twice were excluded. To reduce heterogeneity of
the study population, women were respectively excluded
due to their foreign nationality and first instrumental va-
ginal delivery. We ultimately included women with
spontaneous vaginal delivery (SVD group) and those
with CS (CS group) in the first delivery into the analysis.
Study design and definitions
A retrospective cohort study design was used, and there
were two groups according to the first mode of delivery
in the cohorts. In consideration of the effects of indica-
tions for first CS on the next pregnancy, a subgroup ana-
lysis was performed between the previous SVD group
and previous non-indicated CS group. Potential con-
founders were extracted, including birth place, national-
ity, insurance, marital status, age at second delivery,
height, body mass index (BMI), education level, gravid-
ity, and interpregnancy interval. Age was given in com-
pleted years at the time of delivery and was further
subgrouped into < 25, 25–29, 30–34, 35–39, and ≥
40 years. Height was classified into < 155, 155–164.9,
165–174.9, and ≥ 175 cm. BMI was calculated by divid-
ing antenatal booking weight (kg) by height squared (m)
and was then recoded into the following five categories:
< 18.5, 18.5 to 24.9, 25 to 29.9, and ≥ 30 kg/m2. Educa-
tional level was given as the higher level of the couple,
which was divided into five groups (≤9, 10–12, 13–15,
and ≥ 16 years). Interpregnancy interval (< 1, 1–3, 3–5,
5–10, and ≥ 10 years) was defined as the time elapsed
from the date of the first delivery to the date of subse-
quent conception adjusted by ultrasound with the unit
Hu et al. BMC Pregnancy and Childbirth  (2018) 18:273 Page 2 of 12
of measurement recorded in years. In terms of outcomes
at first birth, women with pregnancy-induced hyperten-
sion (PIH), preeclampsia (PE), gestational diabetes melli-
tus (GDM), preterm delivery, low birth weight (LBW),
macrosomia, or stillbirths in the first birth were com-
pared in groups to assess differences.
In the second pregnancy, the following outcomes were
assessed: PIH (diastolic blood pressure > 90 mmHg on
two occasions 4 h apart or a single reading of >
110 mmHg from 20 weeks gestation), PE (PIH and pro-
teinuria 0.3 g/24 h) [28, 29], GDM (diagnosed using a
2-h, 75 g oral glucose tolerance test) [30], gestational an-
aemia (anaemia occurred in subsequent pregnancy, ex-
cluding haematological diseases and history of anaemia),
gestational thyroid dysfunction (thyroid dysfunction
existed during the subsequent pregnancy, excluding sur-
gery history of the thyroid, prior diagnosis of thyroid dis-
eases, and taking medicines that influence thyroid
function), intrahepatic cholestasis of pregnancy (ICP),
premature rupture of membranes (PROM, defined as
rupture of fetal membranes at least 1 h prior to the on-
set of labour) [31], fetal distress, meconium-staining of
the amniotic fluid, amniotic fluid volume (AFV), placen-
tal abruption and placenta previa (placental abruption
was defined as premature separation of a normally im-
planted placenta from the uterus, while placenta previa
was defined as implantation of the placenta over or near
the internal opening of the cervix), placenta accreta (pla-
centa accreta refers to the entire spectrum of conditions,
including accreta, increta, and percreta, as well as to
cases of clinically apparent morbidly adherent placenta)
[32, 33], rupture of the uterus, antepartum haemorrhage
(APH), fetal growth restriction (FGR), abnormal fetal
position, dystocia, antepartum fever, mode of delivery
(spontaneous vaginal, instrumental, or CS) in subsequent
pregnancy, postpartum haemorrhage (PPH; blood loss >
500 ml for vaginal delivery, > 1000 ml for caesarean),
and puerperal infection. Neonatal outcomes included
stillbirth (delivery of a dead baby at or after 24+ 0 weeks
gestation), preterm (24+ 0 to 36+ 6 weeks of gestation),
LBW (< 2500 g), macrosomia (> 4000 g), Apgar score at
1 min, neonatal infection, neonatal death (death of a
liveborn infant in the first 4 weeks of life), admission to
a neonatal intensive care unit, neonatal respiratory dis-
tress syndrome (NRDS), transient tachypnea of newborn
(TTN), neonatal jaundice, and birth injury.
The primary indications for CS were divided into 3
categories: maternal indications, fetal indications, and
maternal request with no obstetric reasons. To clarify
these indications, we divided caesarean deliveries into 2
categories, medically indicated or non-medically indi-
cated [11]. Medically indicated CS included fetal distress;
prolonged labour (dystocia); cephalopelvic disproportion;
malpresentation; PE or eclampsia; haemolysis, elevated
liver enzyme, and low platelets syndrome (HELLP); ICP;
placental abruption; placenta praevia; scarred uterus; oli-
gohydramnios; intrauterine infection; and suspected
macrosomia. Non-medically indicated CS was defined as
a primary CS done on maternal request without medical
indication (CDMR) or a physician documented “social
influence”. These included: elderly primigravida as the
only indication, a “precious” infant-defined as in vitro
pregnancy or poor obstetric history, severe myopia, iso-
lated PROM without fetal heart rate (FHR) abnormal-
ities, request for concomitant myomectomy or ovarian
cystectomy, or other factors (isolated chronic hyperten-
sion; gestational hypertension; diabetes mellitus without
macrosomia).
Statistical analyses
Statistical analyses were performed using SPSS version
20 software (IBM, SPSS Statistics, Armonk, NY, USA).
Descriptive statistics were reported as the means and
standard deviations for continuous variables and per-
centages for categorical variables. Differences in demo-
graphics and first birth outcomes in the cohorts were
assessed using the Pearson Chi-square test or Fisher’s
exact test. Odds ratios (ORs) with their 95% confidence
intervals (CIs) were calculated to evaluate the associ-
ation between CS in the first delivery and perinatal out-
comes in the subsequent pregnancy via univariate
(unadjusted for covariates) and multivariate statistical
methods (adjusted for potential confounders to ascertain
that relationships were due to demographic characteris-
tics or adverse obstetric events). Variables found to be
statistically significant in univariate analysis and con-
firmed as a risk factor by published literature were en-
tered into the multivariate logistic regression model.
Statistical significance was set at P < 0.05.
Results
In total, 59,831 singleton births were recorded in the
International Peace Maternity and Child Health Hospital
between January 2013 and December 2016, and 12,390
who had a delivery history were treated as potential sub-
jects. After excluding 49 women with missing informa-
tion on the previous mode of delivery, 21 women with
multiple pregnancies in the first birth, 329 women with
parity over twice, 136 women with foreign nationality,
and 187 women with instrumental vaginal delivery in
the first birth, 11,662 subjects were included into the
final analysis (6240 in the SVD group and 5422 in the
CS group). Among the 5422 women in the CS group,
3595 (66.3%) women had medical indications for CS,
and 1827 (33.7%) women had no medical indications for
CS in their first birth (Fig. 1).
The demographic characteristics among the groups
are compared in Table 1. Significant differences were
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detected when comparing the CS group with the SVD
group, including insurance, age at the subsequent deliv-
ery, height, maternal BMI, educational level, gravidity,
and interpregnancy interval, while no differences in race
were observed.
A comparison of the characteristics of the first birth is
presented in Table 1. Women with an initial caesarean
delivery were significantly more likely to have macroso-
mia (first CS group vs. first SVD group: 10.5% vs. 4.5%;
P < 0.001) in the first birth than those in the SVD group.
In contrast, women with an initial CS were less likely to
have preterm delivery (first CS group vs. first SVD
group: 3.5% vs. 4.3%; P = 0.027) and stillbirths (first CS
group vs. first SVD group: 0.2% vs 1.0%; P < 0.001) in the
first birth than those in the SVD group. There were no
differences between the two groups in PIH, PE, GDM,
or LBW in the first birth. However, there were signifi-
cant differences in all first birth outcomes when compar-
ing previous non-indicated CS to previous SVD.
Table 2 displays the associations between caesarean
delivery in the first birth and maternal outcomes in the
subsequent pregnancy, and the percentages of maternal
outcomes are presented in Fig. 2a. After adjusting for
potential confounders, women with previous CS were
1.38 times more likely to have PIH (95% CI: 1.04–1.82),
1.15 times more likely to have GDM (95% CI: 1.02–
1.29), 1.72 times more likely to have ICP (95% CI: 1.04–
2.84), 2.50 times more likely to have polyhydramnios
(95% CI: 1.69–3.69), 2.11 times more likely to have pla-
centa previa (95% CI: 1.52–2.94), 2.11 times more likely
to have placenta accreta (95% CI: 1.47–3.04), 364.21
times more likely to choose caesarean delivery (95% CI:
294.74–450.06), and 8.3 times more likely to suffer in-
strumental vaginal delivery (95% CI: 4.41–15.6) in the
next pregnancy. In contrast, the previous CS women
were 66% less likely to have PROM (95% CI: 0.30–0.39),
67% less likely to suffer from fetal distress (95% CI:
0.27–0.40), 51 and 85% less likely to have moderate or
severe meconium-staining of the amniotic fluid (95% CI:
0.39–0.62 and 0.11–0.19, respectively), respectively, and
46% less likely to have antepartum fever (95% CI: 0.33–
0.89) in the next pregnancy. Given the risk of the first
CS with medical indications in the subsequent preg-
nancy, we performed a subgroup analysis of pregnancy
outcomes in women who did not have indications in the
first delivery. In this subgroup, women with previous
non-indication CS were more likely to experience PIH
(adjusted OR: 2.20; 95% CI: 1.59–3.05), GDM (adjusted
OR: 1.82; 95% CI: 1.57–2.11), gestational anaemia (ad-
justed OR: 1.27; 95% CI: 1.05–1.55), polyhydramnios
(adjusted OR: 2.60; 95% CI: 1.57–4.31), placenta previa
(adjusted OR: 3.18; 95% CI: 2.15–4.71), placenta accreta
(adjusted OR: 2.75; 95% CI: 1.75–4.31), and CS (adjusted
OR: 694.16; 95% CI: 468.45–1028.62). Seven women had
uterine rupture in a subsequent pregnancy in the CS
group, four of whom had a non-indicated CS in the first
birth, but none of the women in the SVD group had
uterine rupture.
Table 3 shows the association between previous cae-
sarean delivery and neonatal outcomes in the subsequent
Fig. 1 Flow chart showing study population in cohorts
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Table 1 Maternal baseline characteristics and the first birth characteristics among women with previous SVD and those with
previous CS and non-indicated CS
previous SVD (n = 6240) previous CS (n = 5422) P- valuea previous non-indicated CS (n = 1827) P-
valuebN % N % N %
Baseline characteristics
Birth place
Shanghai 4753 76.2% 3991 73.6% 0.001 1413 77.3% 0.300
Out of Shanghai 1487 23.8% 1431 26.4% 414 22.7%
Race
Han 6164 98.8% 5353 98.7% 0.791 1812 99.2% 0.158
Minority 76 1.2% 69 1.3% 15 0.8%
Insurance
Public 4239 67.9% 3376 62.3% < 0.001 1099 60.2% < 0.001
Self-pay 2001 32.1% 2046 37.7% 728 39.8%
Marital status
Married/cohabitating 6158 99.7% 5366 99.5% 0.093 1802 99.3% 0.007
Not married/cohabitating 17 0.3% 25 0.5% 13 0.7%
Age at the second delivery
<25 years 73 1.2% 39 0.8% < 0.001 10 0.5% < 0.001
25–29 years 1152 18.5% 739 13.6% 228 12.5%
30–34 years 3055 48.9% 2727 50.3% 917 50.2%
35–39 years 1702 27.3% 1693 31.2% 585 32.0%
≥ 40 years 258 4.1% 224 4.1% 87 4.8%
Height (cm)
<155 222 3.6% 317 5.8% < 0.001 91 5.0% 0.001
155–164.9 4013 64.3% 3651 67.4% 1206 66.0%
165–174.9 1935 31.0% 1419 26.2% 520 28.5%
≥ 175 70 1.1% 35 0.6% 10 0.5%
Maternal BMI (Kg/m2)
<18.5 550 8.8% 405 7.5% < 0.001 139 7.6% < 0.001
18.5–24.9 5313 85.2% 4530 83.5% 1507 82.5%
25–29.9 338 5.4% 423 7.8% 155 8.5%
≥ 30 39 0.6% 64 1.2% 26 1.4%
Educational level (years)
≤ 9 266 4.4% 205 3.9% 0.042 35 2.0% < 0.001
10–12 494 8.2% 469 9.0% 130 7.4%
13–15 1205 20.1% 1119 21.6% 398 22.5%
≥ 16 4049 67.3% 3399 65.5% 1203 68.1%
Gravidity
≤ 2 2984 47.8% 2366 43.6% < 0.001 825 45.2% 0.045
≥ 3 3256 52.2% 3056 56.4% 1002 54.8%
Interpregnancy interval (years)
<1 431 7.0% 88 1.6% < 0.001 29 1.6% < 0.001
1–3 1935 31.2% 1350 25.0% 446 24.5%
3–5 1357 21.9% 1521 28.2% 540 29.6%
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pregnancy, and the percentages of neonatal outcomes
are displayed in Fig. 2b. After adjusting for potential
confounders, previous CS women were 1.37 times more
likely to have preterm delivery (95% CI: 1.14–1.66), 4.25
times more likely to have a baby with LBW (95% CI:
2.73–6.62), 4.79 times more likely to have macrosomia
(95% CI: 3.94–5.83), and 1.39 times more likely to have
their baby admitted to a neonatal unit (95% CI: 1.16–
1.65) compared with women who had a first SVD. Ba-
bies with TTN (adjusted OR: 1.93; 95% CI: 1.33–2.81)
were more common in women with a first CS, as were
neonatal jaundice (adjusted OR: 1.72; 95% CI: 1.39–
2.14). However, there were no differences in stillbirth or
neonatal death in the subsequent pregnancy between the
previous CS and SVD groups (95% CI: 0.27–2.18 and
0.34–13.74, respectively). Given the risk of the first CS
with medical indications in the subsequent pregnancy,
we performed a subgroup analysis of neonatal outcomes
in women who did not have indications in the first deliv-
ery. In this subgroup, women with previous
non-indication CS were 1.37 times more likely to have
preterm delivery (95% CI: 1.06–1.78), 3.78 times more
likely to have a baby with LBW (95% CI: 2.07–6.90),
5.04 times more likely to have macrosomia (95% CI:
3.95–6.44), and 1.58 times more likely to have a baby
with neonatal jaundice (95% CI: 1.17–2.13) than women
in the SVD group.
Discussion
Main findings
Our results indicate that having a CS in the first single-
ton pregnancy is associated with an increased risk of ad-
verse maternal and neonatal outcomes in subsequent
singleton pregnancy in comparison to an initial SVD.
The outcomes included a higher risk of PIH, GDM, ICP,
polyhydramnios, placental previa, placental accreta,
Table 1 Maternal baseline characteristics and the first birth characteristics among women with previous SVD and those with
previous CS and non-indicated CS (Continued)
previous SVD (n = 6240) previous CS (n = 5422) P- valuea previous non-indicated CS (n = 1827) P-
valuebN % N % N %
5–10 1816 29.3% 1957 36.2% 665 36.5%
≥ 10 657 10.6% 485 9.0% 142 7.8%
First birth characteristics
PIH
Yes 109 1.7% 103 1.9% 0.538 65 3.6% < 0.001
No 6131 98.3% 5319 98.1% 1762 96.4%
PE
Yes 81 1.3% 90 1.7% 0.105 40 2.2% 0.006
No 6159 98.7% 5332 98.3% 1787 97.8%
GDM
Yes 415 6.7% 378 7.0% 0.492 159 8.7% 0.003
No 5825 93.3% 5044 93.0% 1668 91.3%
Stillbirths
Yes 61 1.0% 10 0.2% < 0.001 0 0.0% < 0.001
No 6179 99.0% 5412 99.8% 1827 100.0%
LBW
Yes 144 2.3% 144 2.7% 0.227 26 1.4% 0.021
No 6096 97.7% 5278 97.3% 1801 98.6%
Macrosomia
Yes 279 4.5% 572 10.5% < 0.001 211 11.5% < 0.001
No 5961 95.5% 4850 89.5% 1616 88.5%
Preterm delivery
Yes 266 4.3% 188 3.5% 0.027 16 0.9% < 0.001
No 5974 95.7% 5234 96.5% 1811 99.1%
SVD spontaneous vaginal delivery, CS caesarean section, BMI body mass index, PIH pregnancy-induced hypertension, PE preeclampsia, GDM gestational diabetes
mellitus, LBW low birth weight
aComparison between previous CS and previous SVD
bComparison between previous non-indicated CS and previous SVD
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N % N % N %
PIH 99 1.6% 131 2.4% 1.54 (1.18–2.00) 1.38 (1.04–1.82)a 75 4.1% 2.66 (1.96–3.60) 2.20 (1.59–3.05)d
PE 84 1.3% 90 1.7% 1.24 (0.92–1.67) 1.22 (0.88–1.69)a 34 1.9% 1.39 (0.93–2.08) 1.24 (0.79–1.94)d
GDM 705 11.3% 736 13.6% 1.23 (1.10–1.38) 1.15 (1.02–1.29)a 371 20.3% 2.00 (1.74–2.30) 1.82 (1.57–2.11)d
Gestational anaemia 455 7.3% 458 8.4% 1.17 (1.03–1.34) 1.13 (0.98–1.30) 166 9.1% 1.27 (1.06–1.53) 1.27 (1.05–1.55)d
Gestational thyroid
disease
256 4.1% 223 4.1% 1.01 (0.84–1.20) 1.03 (0.85–1.24) 64 3.5% 0.85 (0.64–1.12) 0.86 (0.65–1.16)d
ICP 29 0.5% 43 0.8% 1.71 (1.07–2.75) 1.72 (1.04–2.84) 14 0.8% 1.65 (0.87–3.14) 1.65 (0.84–3.23)d
PROM 1217 19.5% 445 8.2% 0.37 (0.33–0.41) 0.34 (0.30–0.39) 140 7.7% 0.34 (0.29–0.41) 0.32 (0.26–0.39)d
fetal distress 493 7.9% 159 2.9% 0.35 (0.29–0.42) 0.33 (0.27–0.40) 55 3.0% 0.36 (0.27–0.48) 0.34 (0.25–0.46)d
meconium-staining of the amniotic fluid
I degree 58 0.9% 50 0.9% 0.91 (0.62–1.33) 0.94 (0.63–1.40) 17 0.9% 0.91 (0.53–1.57) 0.97 (0.56–1.70)d
II degree 236 3.8% 114 2.1% 0.51 (0.41–0.64) 0.49 (0.39–0.62) 33 1.8% 0.44 (0.30–0.63) 0.39 (0.26–0.57)d
III degree 472 7.6% 67 1.2% 0.15 (0.12–0.19) 0.15 (0.11–0.19) 17 0.9% 0.11 (0.07–0.18) 0.11 (0.07–0.18)d
AFV
Oligohydramnios 65 1.0% 67 1.2% 1.20 (0.85–1.69) 1.15 (0.81–1.64) 25 1.4% 1.33 (0.84–2.12) 1.37 (0.85–2.21)d
Polyhydramnios 39 0.6% 82 1.5% 2.45 (1.67–3.59) 2.50 (1.69–3.69) 27 1.5% 2.39 (1.46–3.92) 2.60 (1.57–4.31)d
Placental abruption 19 0.3% 7 0.1% 0.42 (0.18–1.01) 0.51 (0.21–1.25) 4 0.2% 0.72 (0.24–2.11) 0.92 (0.30–2.80)d
Placenta previa 66 1.1% 124 2.3% 2.19 (1.62–2.96) 2.11 (1.52–2.94) 62 3.4% 3.29 (2.31–4.67) 3.18 (2.15–4.71)d
Placenta accreta 53 0.8% 104 1.9% 2.28 (1.64–3.18) 2.11 (1.47–3.04) 45 2.5% 2.95 (1.97–4.40) 2.75 (1.75–4.31)d
Rupture of uterus 0 0.0% 7 0.1% / / 4 0.2% / /
APH 61 1.0% 59 1.1% 1.11 (0.78–1.60) 0.96 (0.64–1.43) 25 1.4% 1.41 (0.88–2.25) 1.13 (0.66–1.93)d
FGR 82 1.3% 70 1.3% 0.98 (0.71–1.35) 0.93 (0.65–1.33) 22 1.2% 0.92 (0.57–1.47) 0.89 (0.53–1.51)d
Abnormal fetal
position
193 3.1% 194 3.6% 1.16 (0.95–1.42) 1.09 (0.88–1.35) 47 2.6% 0.83 (0.60–1.14) 0.77 (0.55–1.09)d
Dystocia 197 3.2% 196 3.6% 1.15 (0.94–1.41) 1.09 (0.88–1.34) 46 2.5% 0.79 (0.57–1.10) 0.73 (0.52–1.04)d
Antepartum fever 55 0.9% 27 0.5% 0.56 (0.36–0.89) 0.54 (0.33–0.89) 9 0.5% 0.56 (0.28–1.13) 0.60 (0.29–1.24)d
Mode of delivery










80 1.3% 14 0.3% 7.18 (3.97–
13.01)
8.30 (4.41–15.60)b 1 0.1% 2.15 (0.29–
15.96)
6.40 (0.84–48.80)e
PPH 119 1.9% 107 2.0% 1.04 (0.80–1.35) 0.69 (0.42–1.14)c 43 2.4% 1.24 (0.87–1.76) 0.54 (0.30–0.97)f
Puerperal infection 16 0.3% 15 0.3% 1.08 (0.53–2.19) 0.99 (0.35–2.83)c 4 0.2% 0.85 (0.29–2.56) 0.50 (0.12–2.19)f
SVD spontaneous vaginal delivery, CS caesarean section, PIH pregnancy-induced hypertension, PE preeclampsia, GDM gestational diabetes mellitus, ICP
intrahepatic cholestasis of pregnancy, PROM prelabour rupture of membranes, AFV amniotic fluid volume, APH antepartum haemorrhage, PPH postpartum
haemorrhage, FGR fetal growth restriction, OR odds radio, CI confidence interval
Model 1: all ORs adjusted for birth place, insurance, age at the second delivery, height, maternal BMI, educational level, gravidity, interpregnancy interval
aORs further adjusted for PIH, PE and GDM in first birth
bORs further adjusted for PIH, GDM, ICP, gestational anaemia, PROM and meconium-staining of the amniotic fluid, AFV, fetal distress, placental abruption, placenta
previa, placenta accreta, rupture of uterus and antepartum fever
cORs further adjusted for PIH, GDM, ICP, gestational anaemia, PROM and meconium-staining of the amniotic fluid, AFV, fetal distress, placental abruption, placenta
previa, placenta accreta, rupture of uterus, antepartum fever and mode of delivery
Model 2: all ORs adjusted for insurance, marital status, age at the second delivery, height, maternal BMI, educational level, gravidity, interpregnancy interval
dORs further adjusted for PIH, PE and GDM in first birth
eORs further adjusted for PIH, GDM, gestational anaemia, PROM, meconium-staining of the amniotic fluid, AFV, fetal distress, placenta previa, placenta accreta,
rupture of uterus
fORs further adjusted for PIH, GDM, gestational anaemia, PROM and meconium-staining of the amniotic fluid, AFV, fetal distress, placenta previa, placenta accreta,
rupture of uterus and mode of delivery
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repeated caesarean delivery in the mother and preterm
delivery, LBW, macrosomia, admission to a neonatal
unit, TTN, and jaundice in the baby. Notably, in women
without indications for CS in the first birth, there was
still a significantly increased risk of PIH, GDM, polyhy-
dramnios, placental previa, placental accrete, repeated
caesarean delivery, and preterm, LBW, macrosomia, and
neonatal jaundice.
Strengths and limitations
To the best of our knowledge, this is one of the few epi-
demiological studies exploring the association between
CS in the first birth and perinatal complications in the
subsequent pregnancy. There are several advantages to
our study. First, the data analysed were taken from a
geographically stable population and collected at the
time of delivery from case notes, thereby minimizing se-
lection and recall bias. Second, changes in clinical prac-
tice are unlikely to influence the findings, as the data of
the two groups were recorded during the same period.
Last but not least, we restricted our analyses to women
with a second singleton birth, which eliminated potential
confounding effects of parity and multiple gestations,
and we also performed a subgroup analysis between pre-
vious non-indicated CS and previous SVD to avoid the
risk of CS indications in the next pregnancy. Still, we
should note that the presence of missing values and the
retrospective nature of data collection may have biased
the results to some extent. Briefly, the lack of adverse
maternal outcomes in the first birth, such as PROM, pla-
centa previa, and APH, which may be risk factors that
need to be adjusted to adverse outcomes in the next
pregnancy, may have influenced the results. It was diffi-
cult to confirm the indications for CS from the retro-
spective data. Further prospective studies are required to
reduce the information bias. Additionally, as the study
was restricted to a single centre in Shanghai, the results
may only be generalizable to that local area in China.
Interpretation
In our study population, 45.7% of the subjects experi-
enced CS in the first singleton birth, and 33.7% of them
Fig. 2 Incidences of the main perinatal outcomes of the second births. a Percentages of the main maternal outcomes of the second births
among the three groups. b Percentages of the main neonatal outcomes of second births among the three groups. SVD: spontaneous vaginal
delivery; CS: caesarean section; PIH: pregnancy-induced hypertension; PE: preeclampsia; GDM: gestational diabetes mellitus; PROM: premature
rupture of membranes
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were non-indicated. The main reason for the high rate
of CS and non-indicated CS may be attributed to the
One Child Policy of the Chinese government during the
period from 1978 to 2015. In the second singleton birth,
the CS rate reached 52.3%, which was approximately
three times the proportion recommended by the WHO.
This finding is consistent with studies reported previ-
ously in China [9, 34]. We confirmed that some of the
known baseline characteristics were associated with de-
livery mode, including maternal age, height, maternal
BMI, educational level of the couples, gravidity, and
interpregnancy interval, but these factors are not specific
and were associated with a few of the adverse obstetric
outcomes. Our present study findings suggest that CS in
the first birth is linked with adverse maternal and neo-
natal outcomes in the next pregnancy. The effects of
previous CS on the risk of placenta previa and placenta
accreta are consistent with previous studies [24, 26, 27,
35–39]. These papers confirmed the association between
placenta previa and previous CS and found that the ORs
for placenta previa with one or more previous caesarean
deliveries were 1.47–1.66, but the pooled OR of 2.2 from
a meta-analysis [37] is consistent with the OR of 2.11 in
our findings. Additionally, the risk of placenta accreta in
our study was similar to results from previous research
[27, 38]. Possible mechanisms for placenta previa and
accreta following previous CS suggested by previous re-
searchers have included failure of placental apparent mi-
gration, impaired differential growth of the lower uterine
segment, and deficient decidua basalis in the presence of
previous surgery injury [24, 40–42]. In the present study,
we focused on the adverse outcomes in second births,
and our study represents a homogeneous sample af-
fected by previous CS, which ruled out the influence of
parity. Although there is disagreement on the association
of previous CS with a higher risk of placenta abruption
in the second pregnancy in prior studies [24, 26, 27, 36,
38, 39], our study shows that previous CS does not in-
crease the risk of placental abruption. Additionally, the
incidence of uterine rupture (0.1%) in the previous CS
cohort in our study was less than that reported in prior
studies [26, 27, 43–46], which may be attributed to the
lower rate of trial of labour in women with a first CS in
our country. The risks of APH and PPH in our study
were not associated with the initial caesarean delivery,
which is not consistent with previous studies [26, 47].
Even in the subgroup analysis, there were no statistically
significant differences for APH. However, the ORs were
greater than one in the univariate analysis. There are
several possible factors contributing to this finding: first,
the missing information in the first birth may be con-
founding factors, and we cannot be certain whether they




















N % N % N %
Stillbirths 13 0.2% 11 0.2% 0.97 (0.44–2.18) 0.76 (0.27–2.18)a 4 0.2% 1.05 (0.34–3.23) 0.68 (0.13–3.55)a
Preterm delivery 341 5.5% 343 6.3% 1.17 (1.01–1.36) 1.37 (1.14–1.66)b 119 6.5% 1.21 (0.97–1.50) 1.37 (1.06–1.78)b
LBW 162 2.6% 151 2.8% 1.08 (0.86–1.35) 4.25 (2.73–6.62)c 46 2.5% 0.97 (0.70–1.35) 3.78 (2.07–6.90)c
Macrosomia 466 7.5% 317 5.8% 0.77 (0.66–0.89) 4.79 (3.94–5.83)d 110 6.0% 0.79 (0.64–0.98) 5.04 (3.95–6.44)d
Apgar at 1 min<8 79 1.3% 74 1.4% 1.08 (0.78–1.49) 1.13 (0.77–1.66) 25 1.4% 1.08 (0.69–1.70) 1.18 (0.69–2.01)
Neonatal infection 83 1.3% 46 0.8% 0.64 (0.44–0.91) 0.81 (0.54–1.23) 12 0.7% 0.49 (0.27–0.90) 0.51 (0.26–1.03)
Neonatal death 4 0.1% 4 0.1% 1.15 (0.29–4.60) 2.17 (0.34–13.74) 1 0.1% 0.85 (0.10–7.64) 0.70 (0.02–34.51)
Admission to neonatal
unit
366 5.9% 355 6.5% 1.12 (0.97–1.31) 1.39 (1.16–1.65) 117 6.4% 1.10 (0.89–1.36) 1.20 (0.94–1.54)
NRDS 13 0.2% 21 0.4% 1.86 (0.93–3.72) 1.88 (0.83–4.24) 7 0.4% 1.84 (0.73–4.62) 1.49 (0.48–4.61)
TTN 71 1.1% 91 1.7% 1.48 (1.09–2.03) 1.93 (1.33–2.81) 28 1.5% 1.35 (0.87–2.10) 1.55 (0.93–2.58)
Neonatal jaundice 206 3.3% 249 4.6% 1.41 (1.17–1.70) 1.72 (1.39–2.14) 84 4.6% 1.41 (1.09–1.83) 1.58 (1.17–2.13)
Birth injury 16 0.3% 9 0.2% 0.65 (0.29–1.49) 0.85 (0.35–2.06) 4 0.2% 0.85 (0.29–2.56) 0.85 (0.25–2.85)
LBW low birth weight, NRDS neonatal respiratory distress syndrome, TTN transient tachypnea of newborn(TTN)
Model 1: all ORs adjusted for birth place, insurance, age at the second delivery, height, maternal BMI, educational level, gravidity, interpregnancy interval, PIH,
GDM, ICP, gestational anaemia, PROM and meconium-staining of the amniotic fluid, AFV, fetal distress, placental abruption, placenta previa, placenta accreta,
rupture of uterus, antepartum fever
Model 2: all ORs adjusted for insurance, marital status, age at the second delivery, height, maternal BMI, educational level, gravidity, interpregnancy interval, PIH,
GDM, gestational anaemia, PROM and meconium-staining of the amniotic fluid, AFV, fetal distress, placenta previa, placenta accreta, rupture of uterus
aORs further adjusted for stillbirth at the first birth
bORs further adjusted for preterm delivery at the first birth
cORs further adjusted for LBW at the first birth
dORs further adjusted for macrosomia at the first birth
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caused outcomes in the second birth; second, placental
abruption, which is a primary cause of APH, was not in-
creased in the first CS women in our study; third, the re-
peated CS reduced the occurrence of PPH.
Our study seems to be the first to document the associa-
tions between previous CS history and increased risk of
PIH, GDM, ICP, and polyhydramnios in the next preg-
nancy. Especially in women without indications for a pre-
vious CS, the risks were much higher for PIH, GDM, and
polyhydramnios. Similar research has shown the associ-
ation between the first CS and the increased risk of PE
[27, 48, 49], but no differences were found in our study.
Prior CS has been shown to be an important risk factor
for subsequent complications, including placental vascu-
lopathies [50], which may lead to a high risk of PIH. Preg-
nant women with PIH and/or GDM in the first pregnancy
are highly susceptible to recurrence in the next pregnancy
[51, 52]. Thus, in our study, the high proportion of PIH
and GDM in the first birth in the CS group may be a rea-
son for the increased risk of PIH and GDM in the next
pregnancy. Interestingly, when we regarded PIH and
GDM in the first birth as confounding factors and ad-
justed for them, a high risk of PIH and GDM still existed
in the next pregnancy for women with a first CS, espe-
cially in women without indications for the first CS. More-
over, uterine changes induced by prior CS may interfere
with normal trophoblastic invasion and uteroplacental
blood flow in subsequent pregnancies, resulting in abnor-
mal placental function and subsequent gestational compli-
cations, including PIH and GDM [53, 54].
Compared to women with a prior SVD, the risks of
PROM, fetal distress, meconium-staining of the amniotic
fluid, and antepartum fever in the next birth were lower
in women with an initial CS, which may be due to a
missing confounding factor (PROM) in the first birth.
Women with PROM were more likely to choose vaginal
delivery in the first birth. Studies in the UK [31] and
USA [55] showed that a PROM history was associated
with a 6.6- to 20.6-fold increase in the risk of recurrent
PROM. Furthermore, the decreased risk of fetal distress,
meconium-staining of the amniotic fluid, and antepar-
tum fever in women with primary CS in the second birth
may also be related to the risks of these factors in the
first birth.
The stillbirth rates were 2.0/1000 in both the previous
CS group and previous SVD group, which was in ac-
cordance with preceding reports [26, 56], but there were
no differences between the two groups in our research.
Our findings on the effects of the first CS on the risk of
preterm, LBW, macrosomia, admission to a neonatal
unit, TTN of babies, and neonatal jaundice in the second
pregnancy are consistent with previous studies [26, 43,
57, 58]. There are few published studies providing evi-
dence to support our findings; therefore, it is difficult to
interpret the risk of caesarean delivery on these out-
comes. Although there was a higher risk of admission to
a neonatal unit for babies of first CS women in the next
pregnancy, it did not increase their neonatal death rate.
Additionally, in the subgroup analysis, there was no dif-
ference in admission to a neonatal unit and TTN in the
two groups.
With implementation of the “two-child policy” in
China, an increasing number of families will choose to
raise two children. To control the overall CS rate, it is
important to decrease the occurrence of primary CS, es-
pecially elective CS with no medical indications. These
study findings will help women and clinical doctors in
making choices and balancing the risks and benefits of a
caesarean delivery in the first and subsequent births.
The decision for an elective primary caesarean delivery
should be carefully considered for its impact on future
births.
Conclusions
CS in the first birth is associated with an increased risk
of repeated caesarean delivery and adverse obstetric and
perinatal outcomes in the following delivery, especially
in women without CS indications. Clinicians might con-
sider this information valuable when counselling women
during pregnancy.
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